HS
EOLS icon

HighVista Strategies’s Evolus EOLS Stock Holding History

HighVista Strategies’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-226,025
Closed -$1.39M – 162
2025
Q3 		$1.39M Buy
226,025
+167,983
+289% +$1.31M 0.34% 93
2025
Q2 		$535K Buy
+58,042
New +$594K 0.2% 123

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HighVista Strategies's EOLS Position: Q4 2025 in Review

HighVista Strategies sold out of Evolus (EOLS) in Q4 2025, closing a stake of 226,025 shares — an estimated $1.39M sold.

HighVista Strategies first reported a position in EOLS in Q2 2025 and held it in 2 quarters. The position peaked at $1.39M in Q3 2025. 169 funds tracked by Wall St. Rank hold EOLS as of Q4 2025.

  • HighVista Strategies reported no remaining Evolus position as of Q4 2025 after selling out during the quarter.
  • HighVista Strategies sold 226,025 Evolus shares in Q4 2025, an estimated $1.39M.
  • HighVista Strategies first reported a position in Evolus in Q2 2025 and held it in 2 quarters.
  • HighVista Strategies's Evolus position peaked at $1.39M in Q3 2025.
  • 169 funds tracked by Wall St. Rank held Evolus as of Q4 2025.

Based on HighVista Strategies's 13F filing for Q4 2025, filed 17 Feb 2026.